Alera Investment Advisors, LLC Repligen Corp Transaction History

Alera Investment Advisors, LLC

  • $838 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023
SELL
$162.42 - $220.56 $2,436 - $3,308
-15 Reduced 0.65%
2,288 $387,000
Q3 2022

Nov 09, 2022
BUY
$160.42 - $256.21 $6,577 - $10,504
41 Added 1.81%
2,303 $431,000
Q2 2022

Aug 08, 2022
BUY
$140.68 - $188.02 $140 - $188
1 Added 0.04%
2,262 $368,000
Q1 2022

May 10, 2022
BUY
$161.19 - $257.96 $364,450 - $583,247
2,261 New
2,261 $425,000

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Alera Investment Advisors, LLC Portfolio

Follow Alera Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alera Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alera Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email